Sun, Wockhardt recall drugs from US market

Hyderabad: Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.

Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-¬release Tablets USP (SR), 200 mg, 60-count bottle, from the US market for “failed dissolution specification”, while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg from the same market for “CGMP violations”.

According to a notification issued by the US Food and Drug Administration, Sun Pharma’s recall was initiated last month under Class-III classification which was as ‘a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences’

read at……http://www.firstpost.com/business/sun-wockhardt-recall-drugs-from-us-market-2413690.html

Advertisement

6 Drugs Whose Dangerous Risks Were Buried So Big Pharma Could Make Money

New meds are rushed to the market so industry can start making money even before safety has been determined.

January 15, 2014  |

Editor’s note: The following article is a follow up to a previous AlterNet piece about drugs whose dangerous side-effects emerged only after the pharmaceutical industry’s patents ran out.

READ AT

http://www.alternet.org/personal-health/6-drugs-whose-dangerous-risks-were-buried-so-big-pharma-could-make-money#

Sixteen prescription drugs made in India recalled by UK watchdog

Sixteen prescription drugs made in India recalled by UK watchdog
Sixteen prescription drugs produced at an Indian factory that failed a routine inspection have been recalled by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

http://www.pharmaceutical-technology.com/news/newssixteen-prescription-drugs-made-in-india-recalled-by-uk-watchdog?WT.mc_id=DN_News